The Humanistic Burden of Advanced Non-Small Cell Lung Cancer Patients in Europe - A Real World Survey

被引：0
|
作者：
Taylor-Stokes, Gavin [1 ]
Wood, Robert [1 ]
Malcolm, Bill [2 ]
Lees, Michael [3 ]
Chirita, Oana [2 ]
机构：
[1] Adelphi Real World, Bollington, England
[2] Bristol Myers Squibb, Uxbridge, Middx, England
[3] Bristol Myers Squibb, Rueil Malmaison, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
NSCLC; humanistic burden; quality of life; Real world;
D O I：
10.1016/j.jtho.2016.11.896
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.06-032
引用
收藏
页码：S685 / S685
页数：1
相关论文
共 50 条
  • [21] Real-World Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US
    Nadler, E.
    Chang, J.
    Zhang, X.
    Aguilar, K.
    Zhou, J.
    Arondekar, B.
    Pawar, V.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S38 - S39
  • [22] Are the Real World Patients with Advanced Non-Small Cell Lung Cancer Represented in Phase III Immunotherapy Trials?
    Ce Coelho, J.
    Rebelato, T.
    Gelatti, A.
    D'Avila, R.
    Geib, G.
    Rubini Liedke, P.
    Peres Pereira, R.
    Werutsky, G.
    Jobim De Azevedo, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1918 - S1918
  • [23] Real-World Treatment Patterns and Outcomes for Patients With Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S319 - S319
  • [24] Immunotherapy in Hispanic patients with advanced non-small cell lung cancer: A real-world data.
    Lujan, Mauricio
    Lema, Mauricio
    Preciado, Beatriz
    Lema, Camila
    Egurrola, Jorge
    Zorrilla, Andres Felipe Cardona
    Gonzalez, Diego Mauricio
    Mantilla, William Armando
    Pino, Luis
    Rojas, Gustavo
    Gomez-Abreo, Diego Andres
    Munevar, Isabel
    Manneh, Raimundo
    Kopp, Ray Manneh
    Lobaton, Jose F.
    Calle, Esteban
    Borras, Mariana
    Triana, Ivan Camilo
    Pineda, Mateo
    Ortio, Diego Moran
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhong, Qiuxia
    Liu, Zhihua
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4115 - 4128
  • [26] Real-world treatment patterns and outcomes in patients (pts) with advanced, ALK plus non-small cell lung cancer (NSCLC) in Europe
    Stoyanov, N.
    Anderson, D.
    Combest, A.
    Nguyen, B.
    Ognar, R.
    Reitsma, D.
    Capart, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S860 - S860
  • [27] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Fen Wang
    Feng Jin
    Boran Cheng
    Yue Zhang
    Qing Zhou
    Shubin Wang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1721 - 1735
  • [28] Real-world treatment sequencing in advanced non-small cell lung cancer (aNSCLC).
    Radtchenko, Janna
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
  • [30] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Wang, Fen
    Jin, Feng
    Cheng, Boran
    Zhang, Yue
    Zhou, Qing
    Wang, Shubin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1721 - 1735
12345